All three H2020 projects (SWINOSTICS, I-Cuvette, GRACED) center on biosensing technologies using photonics, plasmonics, or fluorescence.
ISS BIOSENSE SRL
Italian SME developing portable photonic biosensors for rapid agri-food quality testing and veterinary disease diagnostics.
Their core work
ISS BioSense is a Naples-based SME that develops portable biosensor devices for rapid on-site detection in agri-food and veterinary diagnostics. Their core work involves integrating photonic integrated circuits (PICs), plasmonics, and fluorescence-based sensing into compact analytical instruments. They have built expertise in automating lab-grade analysis — such as milk quality testing and swine disease screening — into field-deployable, low-cost sensor platforms suited for food supply chains and livestock health monitoring.
What they specialise in
SWINOSTICS focused on field diagnostics for six major swine diseases (ASF, PRRS, CSF, PCV2, PPV, SIV) using PIC-based biosensors.
I-Cuvette targeted rapid milk analysis; GRACED addresses fruits and vegetables value chain monitoring.
GRACED (2021-2024) develops ultra-compact plasmo-photonic bimodal platforms with quantum dots and on-chip light generation — a clear technology step-up from earlier work.
How they've shifted over time
ISS BioSense started with established photonic integrated circuit (PIC) technology applied to veterinary diagnostics (SWINOSTICS, 2017) and simple portable fluorescence sensing for milk testing (I-Cuvette, 2017-2018). By 2021, their focus shifted toward more advanced plasmo-photonic platforms incorporating quantum dots, on-chip light generation, and multiplexed detection for agri-food value chains (GRACED). The trajectory shows a company moving from single-analyte portable testing toward multi-analyte, highly integrated sensor platforms with broader application scope.
ISS BioSense is moving toward miniaturized, multi-target sensor platforms that combine plasmonics and photonics — expect them to pursue applications beyond veterinary diagnostics into broader food safety and environmental monitoring.
How they like to work
ISS BioSense primarily participates as a specialist partner in larger consortia (2 of 3 projects), contributing biosensor device expertise to multi-partner research efforts. They coordinated one SME Phase 1 project (I-Cuvette), which suggests entrepreneurial ambition but limited experience leading large consortia. With 23 unique partners across 9 countries from just 3 projects, they integrate well into diverse European teams and bring a focused technical contribution rather than broad project management.
Despite only three projects, ISS BioSense has built a network of 23 partners across 9 countries, indicating they join sizeable, geographically diverse consortia. Their Italian base and agri-food focus likely connect them to Southern and Central European research groups in photonics and agricultural technology.
What sets them apart
ISS BioSense sits at the intersection of advanced photonics and practical agri-food diagnostics — a niche that few SMEs occupy. While many biosensor companies stay in the lab or focus on human health, this team has consistently targeted agricultural and veterinary applications with field-deployable devices. For consortium builders, they offer a rare combination: deep photonic sensor engineering with direct understanding of food chain and livestock end-user requirements.
Highlights from their portfolio
- GRACEDLargest funding (EUR 258,438) and most technically ambitious project, combining plasmonics, quantum dots, and on-chip light generation into multiplexed sensor platforms for food value chains.
- SWINOSTICSAddressed six major swine diseases in a single diagnostic toolbox — a high-impact veterinary application that demonstrates the company's ability to deliver multi-target biosensing in real field conditions.
- I-CuvetteSME Phase 1 project where ISS BioSense was sole coordinator, validating their portable FRET-based milk analysis concept — signals independent product development ambition.